EFFECTOR CD4+T CELLS, RATHER THAN CD8+, INCREASE THE EFFICACY OF ANTIBODY-DRIVEN TUMOR IMMUNITY

被引：0
|
作者：
Gutwillig, A. [1 ]
Rasoulouniriana, D. [1 ]
Santana-Magal, N. [1 ]
Farhat, L. [1 ]
Tal, L. [1 ]
Rider, P. [1 ]
Carmi, Y. [1 ]
机构：
[1] Tel Aviv Univ, Pathol, Tel Aviv, Israel
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
ICLEa19-00
引用
收藏
页码：A21 / A21
页数：1
相关论文
共 50 条
  • [31] Heterogeneity of CD4+ and CD8+ T cells
    Woodland, DL
    Dutton, RW
    CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (03) : 336 - 342
  • [32] Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity
    Christopher M Smith
    Nicholas S Wilson
    Jason Waithman
    Jose A Villadangos
    Francis R Carbone
    William R Heath
    Gabrielle T Belz
    Nature Immunology, 2004, 5 : 1143 - 1148
  • [33] Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity
    Smith, CM
    Wilson, NS
    Waithman, J
    Villadangos, JA
    Carbone, FR
    Heath, WR
    Belz, GT
    NATURE IMMUNOLOGY, 2004, 5 (11) : 1143 - 1148
  • [34] The fate of effector T cells in vivo is determined during activation and differs for CD4+ and CD8+ cells
    Bode, U
    Sahle, A
    Sparmann, G
    Weidner, F
    Westermann, J
    JOURNAL OF IMMUNOLOGY, 2002, 169 (11): : 6085 - 6091
  • [35] CD4 helper T cells maintain CD8 effector T cells to eradicate growing tumor and promote long-term tumor immunity
    Lin, CT
    Huang, CT
    Chang, TC
    Lai, CH
    Soong, YK
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S50 - S51
  • [36] EFFECTS OF CD4+ AND CD8+ T-CELLS IN TUMOR-BEARING MICE ON ANTIBODY-PRODUCTION
    SHIMIZU, M
    IWAGUCHI, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 38 (04) : 272 - 276
  • [37] B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity
    Smith, Aubrey S.
    Knochelmann, Hannah M.
    Wyatt, Megan M.
    Rivera, Guillermo O. Rangel
    Rivera-Reyes, Amalia M.
    Dwyer, Connor J.
    Ware, Michael B.
    Cole, Anna C.
    Neskey, David M.
    Rubinstein, Mark P.
    Liu, Bei
    Thaxton, Jessica E.
    Bartee, Eric
    Paulos, Chrystal M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [38] CD4 on CD8+ T cells directly enhances effector function and is a target for HIV infection
    Kitchen, SG
    Jones, NR
    LaForge, S
    Whitmire, JK
    Vu, BA
    Galic, Z
    Brooks, DG
    Brown, SJ
    Kitchen, CMR
    Zack, JA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (23) : 8727 - 8732
  • [39] Conversion of effector CD4+ T cells to a CD8+ MHC II-recognizing lineage
    Elizabeth Robins
    Ming Zheng
    Qingshan Ni
    Siqi Liu
    Chen Liang
    Baojun Zhang
    Jian Guo
    Yuan Zhuang
    You-Wen He
    Ping Zhu
    Ying Wan
    Qi-Jing Li
    Cellular & Molecular Immunology, 2021, 18 : 150 - 161
  • [40] Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells
    Zhong, WM
    Roberts, AD
    Woodland, DL
    JOURNAL OF IMMUNOLOGY, 2001, 167 (03): : 1379 - 1386
12345